0000899243-23-010711.txt : 20230405
0000899243-23-010711.hdr.sgml : 20230405
20230405160539
ACCESSION NUMBER: 0000899243-23-010711
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230403
FILED AS OF DATE: 20230405
DATE AS OF CHANGE: 20230405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amado Rafael
CENTRAL INDEX KEY: 0001662119
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38205
FILM NUMBER: 23802526
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zai Lab Ltd
CENTRAL INDEX KEY: 0001704292
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
BUSINESS PHONE: 862161632588
MAIL ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-03
0
0001704292
Zai Lab Ltd
ZLAB
0001662119
Amado Rafael
C/O ZAI LAB LIMITED
314 MAIN STREET, 4TH FLOOR, SUITE 100
CAMBRIDGE
MA
02142
0
1
0
0
See Remarks
0
Stock Options (Right to Buy)
33.95
2023-04-03
4
A
0
113217
0.00
A
2033-04-03
American Depositary Shares
113217
113217
D
Restricted Share Units
2023-04-03
4
A
0
21564
0.00
A
American Depositary Shares
21564
21564
D
The Stock Options are exercisable for American Depositary Shares (ADSs). The number of securities underlying each option and the exercise price therefor are represented in ADSs. Each ADS represents ten Ordinary Shares of the issuer.
The Stock Options vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant.
Each ADS represents ten Ordinary Shares of the issuer.
Each Restricted Share Unit represents a contingent right to receive one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer.
The Restricted Share Units vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting.
President, Head of Global Oncology Research and Development
/s/ Bruce Blefeld, Attorney-in-Fact
2023-04-05